Risk indicators of preventable morbidity related to drug utilization;Indicadores de riesgo de morbilidad prevenible causada por medicamentos

Gaceta Sanitaria

Volumn 21, Issue 1, 2007, Pages 29-36

  Dago Martínez, Ana ^a   Arcos González, Pedro ^a   Alvarez de Toledo Saavedra, Flor ^b   Baena Parejo, María Isabel ^b   Martínez Olmos, José ^b   Gorostiza Ormaetxe, Íñigo ^c  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Centro de Salud Paseo de Extremadura   (Spain)

Author keywords

Delphi technique; Medication indicators; Pharmaceutical care; Presentable morbidity

Indexed keywords

EID: 34047146971     PISSN: 02139111     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099118     Document Type: Article

References (35)

1. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to do emergency department: a prospective study. Ann Pharmacother. 1999;33:1252-7.
2. Guemes M, Sanz E, García M. Adverse reactions and other drug-related problems in an emergency service department. Rev Esp Salud Pública. 1999;73:512-8.
3. Tuneu Valls L, García Peláez M, López Sánchez S. Problemas relacionados con los medicamentos en pacientes quo visitan un servicio de urgencias. Pharm Care Esp. 2000; 2:177-92.
4. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31: 199-205.
5. Baena MI, Faus MJ, Morín R, Zarzuelo A, Jiménez-Martín J, Martínez-Olmos J. Problemas de salud relacionados con los medicamentos en un servicio de urgencias hospitalario. Med Clin (Barc). 2005;124:250-5.
6. Salar L, Climent MT, Pascual I, Velert J, Aznar S. Repercusión de PRM en el paciente: estudio piloto. Pharm Care España. 2003;5:82-7.
7. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11:65-72.
8. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34.
9. Lazarou J, Pomeranz BM, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200-5.
10. Vicent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. BMJ. 2001;322:517-9.
11. Hepler CD, Strand LM. Oportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-43.
12. Panel de Consenso ad hoc. Consenso de Granada sobre Problemas Relacionados con los Medicamentos. Pharm Care España. 1999; 1:107-12.
13. Pharmaceutical Care Network of Europe [citado 19 May 2005]. Disponible en: http://www.pcne.org
14. Comité de Consenso. Segundo Consenso sobre Problemas Relacionados con Medicamentos. Ars Pharmacéutica. 2002; 43:175-84.
15. Marco JL, Boscá B, San Martín MD, Borrás J, Díez A. Ingresos hospitalarios por problemas relacionados con la medicación en el Hospital General de Requena (1997-2000). Pharm Care España. 2002;4:286-99.
16. Alonso P, Otero MJ, Maderuelo JA. Ingresos hospitalarios causados por medicamentos: incidencia, características y coste. Farm Hosp. 2002;26:76-90.
17. Rascheti R, Morgutti M, Mennti-Ippolito F, Belisari A, Rossignoli A, Longiní P, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959-63.
18. Otero MJ, Bajo A, Maderuelo JA, Domínguez-Gil A. Evitabilidad de los acontecimientos adversos inducidos por medicamentos detectados en un servicio de urgenclas. Rev Clin Esp. 1999;199:796-805.
19. Martín MT, Codina C, Tuset M, Carné X, Nogué S, Ribas J. Problemas relacionados con la medicación como causa de ingreso hospitalario. Med Clin (Barc). 2002;118:205-10.
20. Baena MI, Fajardo P, Luque FM, Marín R, Arcos A, Zarzuelo A, et al. Problemas relacionados con los medicamentos en usuarios de un servicio de urgencies hospitalario: resultados de la validación de un cuestionario. Pharm Care Esp. 2001;3:345-57
21. McDonnell PJ, Jacobs MR. Hopital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002; 36: 1331-6.
22. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003;12:280-5.
23. Blasco P, Mariño E, Aznar M, Pol E, Alós M, Castells M, et al. Desarrollo de un método observacional prospectivo de estudio de errores de medicación para su aplicación en hospitales. Farm Hosp. 2001;25:253-73.
24. Flanagan PS, MacKinnon NJ, Bowles SK, Kirkland SA. Validation of four clinical indicators of preventable drug-related morbidity. Ann Pharmacother. 2004;38:20-4.
25. Morris C, Cantrill J. Preventable drug-related morbidity indicators in the US and UK. J Manag Care Pharm. 2002;8:372-7.
26. Mackinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults (I). Indicator development. J Manag Care Pharm. 2002;8:365-71.
27. Mackinnon NJ, Helper CD. Indicators of preventable drug-related morbidity in older adults (II). Use within a managed care organization. J Manag Care Pharm. 2003;9:134-41.
28. Morris CJ, Cantrill JA. Preventing drug-related morbidity: the development of quality indicators. J Clin Pharm Ther. 2003; 28:295-305.
29. Robertson HA, MacKinnon NJ. Development of a list of consensus-approved clinical indicators preventable drug-related morbidity in older adults. Clin Ther. 2002;24:1595-613.
30. Morris CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity. Determining valid indicators. Int J Qual Health Care. 2002;14:183-98.
31. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64.
32. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376-80.
33. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ. 2000; 321:1-5.
34. Cantrill JA, Sibbald B, Buetow S. The Delphi and nominal group techniques in health services reseach. Int J Pharm Pract. 1996;4:67-74.
35. Astigarraga E. El método Delphi. Universidad de Deusto. Facultad de CC.EE. y Empresariales [citado 31 Ago 2005). Disponible en: http://www.codesyntax.com/prospectiva/Metodo_delphi.pdf